Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
6601 WEST BROAD STREET, RICHMOND, VA
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
9 Oct 2026

Altria Group, Inc. reported A material agreement

Altria Group, Inc. filed an 8-K covering a material agreement, supporting financial statements or exhibits.

28 Aug 2026

Altria Group, Inc. reported A director or senior management change or compensation event

Altria Group, Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

30 Jul 2026

Altria Group, Inc. filed Form 10-Q

Altria Group, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

30 Jul 2026

Altria Group, Inc. reported Operating or financial results

Altria Group, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

27 May 2026

Altria Group, Inc. filed Form 10-K/A

Altria Group, Inc. submitted Form 10-K/A to the SEC for the period ending Dec 31, 2025.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$2.37B
Total assets (USD)$33.37B
Total liabilities (USD)$35.99B
Shareholders' equity (USD)−$2.67B
Long-term debt (USD)$22.89B
Debt due within a year (USD)$1.68B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance
$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance
$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance
$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance
$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance
$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q2 2026$6.11B$3.14B$2.30B$1.3710-Q · 30 Jul 2026
Q1 2026$5.43B$2.96B$2.18B$1.3010-Q · 30 Apr 2026
Q4 2025$5.85B$1.65B$1.12BUnavailable10-K · 25 Feb 2026
Q3 2025$6.07B$3.23B$2.38B$1.4110-Q · 30 Oct 2025
Q2 2025$6.10B$3.23B$2.38B$1.4110-Q · 30 Jul 2025
Q1 2025$5.26B$1.79B$1.08B$0.6310-Q · 29 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $68.40
-7.4% upside potential
📈
Strong Buy
Unavailable
👍
Buy
3
⏸️
Hold
5
📉
Sell
1
9 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 58.00–77.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
14
Oct 2026
Patterson Katie F
Vice President and Controller
Tax withholding
$71.56 per share
1,268 shares
SEC Form 4
9
Sep 2026
McQUADE KATHRYN B.
Director
Open-market purchase
$67.62 per share
1,500 shares
SEC Form 4
26
May 2026
KELLY ENNIS DEBRA J
Director
Open-market sale
$72.25 per share
5,790 shares
SEC Form 4
26
May 2026
Strahlman Ellen R
Director
Open-market sale
$72.56 per share
2,000 shares
SEC Form 4
14
May 2026
Strahlman Ellen R
Director
Grant or award
Unavailable per share
2,571 shares
SEC Form 4
14
May 2026
Stoddart Richard S
Director
Grant or award
Unavailable per share
2,571 shares
SEC Form 4
14
May 2026
Clarke Ian L.T.
Director
Grant or award
Unavailable per share
2,571 shares
SEC Form 4
14
May 2026
Connelly Marjorie Mary
Director
Grant or award
Unavailable per share
2,571 shares
SEC Form 4

Top Shareholders

Vanguard Group Inc
160,980,626 shares
1.197% change
12/31/2025
Blackrock, Inc.
126,073,166 shares
1.062% change
6/30/2026
Vanguard Capital Management Llc
109,032,952 shares
0.181% change
6/30/2026
State Street Corp
70,192,620 shares
-2.228% change
6/30/2026
Charles Schwab Investment Management Inc
59,122,097 shares
8.92% change
6/30/2026
Capital Research Global Investors
58,653,624 shares
128.403% change
6/30/2026
Geode Capital Management, Llc
47,721,870 shares
1.487% change
6/30/2026
Vanguard Portfolio Management Llc
33,719,478 shares
-4.228% change
6/30/2026
Gqg Partners Llc
25,111,622 shares
5.348% change
6/30/2026
Morgan Stanley
22,702,935 shares
-7.167% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 11 hours ago